BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37205907)

  • 1. Editorial: Pharmacogenetics and pharmacogenomics in Latin America: ethnic variability, new insights in advances and perspectives: a RELIVAF-CYTED initiative, Volume II.
    López-Cortés A; Esperón P; Martínez MF; Redal MA; Lazarowski A; Varela NM; Lares-Asseff I; Quiñones LA
    Front Pharmacol; 2023; 14():1211712. PubMed ID: 37205907
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Pharmacogenetics and Pharmacogenomics in Latin America: Ethnic Variability, New Insights in Advances and Perspectives: A RELIVAF-CYTED Initiative.
    Esperón P; Martínez MF; Redal MA; Lazarowski A; López-Cortés A; Varela NM; Quiñones LA
    Front Pharmacol; 2021; 12():833000. PubMed ID: 35087412
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenetics and ethnicity: relevance for clinical implementation, clinical trials, pharmacovigilance and drug regulation in Latin America.
    Sosa-Macías M; Teran E; Waters W; Fors MM; Altamirano C; Jung-Cook H; Galaviz-Hernández C; López-López M; Remírez D; Moya GE; Hernández F; Fariñas H; Ramírez R; Céspedes-Garro C; Tarazona-Santos E; LLerena A
    Pharmacogenomics; 2016 Nov; 17(16):1741-1747. PubMed ID: 27790935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics in Latin American populations: regulatory aspects, application to herbal medicine, cardiovascular and psychiatric disorders.
    Rodeiro I; Remírez-Figueredo D; García-Mesa M; Dorado P; LLerena A;
    Drug Metabol Drug Interact; 2012; 27(1):57-60. PubMed ID: 22718626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perception of the usefulness of drug/gene pairs and barriers for pharmacogenomics in Latin America.
    Quinones LA; Lavanderos MA; Cayun JP; Garcia-Martin E; Agundez JA; Caceres DD; Roco AM; Morales JE; Herrera L; Encina G; Isaza CA; Redal MA; Larovere L; Soria NW; Eslava-Schmalbach J; Castaneda-Hernandez G; Lopez-Cortes A; Magno LA; Lopez M; Chiurillo MA; Rodeiro I; Castro de Guerra D; Teran E; Estevez-Carrizo F; Lares-Assef I
    Curr Drug Metab; 2014 Feb; 15(2):202-8. PubMed ID: 24524664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conference scene: Latin American Pharmacogenomics and Personalized Medicine Conference.
    Suarez-Kurtz G
    Pharmacogenomics; 2012 Oct; 13(13):1449-52. PubMed ID: 23057544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Institutional Profile: Golden Helix Institute of Biomedical Research: interdisciplinary research and educational activities in pharmacogenomics and personalized medicine.
    Mitropoulos K; Innocenti F; van Schaik RH; Lezhava A; Tzimas G; Kollia P; Macek M; Fortina P; Patrinos GP
    Pharmacogenomics; 2012 Mar; 13(4):387-92. PubMed ID: 22379996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.
    Céspedes-Garro C; Naranjo MG; Rodrigues-Soares F; LLerena A; Duconge J; Montané-Jaime LK; Roblejo H; Fariñas H; Campos ML; Ramírez R; Serrano V; Villagrán CI; Peñas-LLedó EM
    Pharmacogenomics; 2016 Oct; 17(15):1707-1724. PubMed ID: 27633613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics guidelines: Current status and future development.
    Guo C; Xie X; Li J; Huang L; Chen S; Li X; Yi X; Wu Q; Yang G; Zhou H; Liu JP; Chen X
    Clin Exp Pharmacol Physiol; 2019 Aug; 46(8):689-693. PubMed ID: 31009088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics: historical perspective and current status.
    Charlab R; Zhang L
    Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Diversity in Pharmacogenetics: A Latin American Perspective.
    Suarez-Kurtz G; Parra EJ
    Adv Pharmacol; 2018; 83():133-154. PubMed ID: 29801573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.
    Naranjo MG; Rodrigues-Soares F; Peñas-Lledó EM; Tarazona-Santos E; Fariñas H; Rodeiro I; Terán E; Grazina M; Moya GE; López-López M; Sarmiento AP; Calzadilla LR; Ramírez-Roa R; Ortiz-López R; Estévez-Carrizo FE; Sosa-Macías M; Barrantes R; LLerena A;
    OMICS; 2018 Sep; 22(9):575-588. PubMed ID: 30183544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials in pharmacogenetics and pharmacogenomics: methods and applications.
    Rioux PP
    Am J Health Syst Pharm; 2000 May; 57(9):887-98; quiz 899-901. PubMed ID: 10840530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Latin America and the Caribbean: a report from the Global Opioid Policy Initiative (GOPI).
    Cleary J; De Lima L; Eisenchlas J; Radbruch L; Torode J; Cherny NI
    Ann Oncol; 2013 Dec; 24 Suppl 11():xi41-50. PubMed ID: 24285228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients.
    Qin W; Du Z; Xiao J; Duan H; Shu Q; Li H
    Pharmacogenomics; 2020 Feb; 21(3):209-219. PubMed ID: 31967514
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical guidelines for Western clinicians engaged in primary care medical service trips in Latin America and the Caribbean: an integrative literature review.
    Dainton C; Chu CH; Lin H; Loh L
    Trop Med Int Health; 2016 Apr; 21(4):470-8. PubMed ID: 26919697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conference report: pharmacogenomics in special populations at WCP2018.
    Suarez-Kurtz G; Aklillu E; Saito Y; Somogyi AA
    Br J Clin Pharmacol; 2019 Mar; 85(3):467-475. PubMed ID: 30537134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics of multifactorial diseases: a focus on psoriatic arthritis.
    Cascella R; Strafella C; Longo G; Maccarone M; Borgiani P; Sangiuolo F; Novelli G; Giardina E
    Pharmacogenomics; 2016 Jun; 17(8):943-51. PubMed ID: 27269419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of pharmacogenomics for developing countries in Europe.
    Mitropoulos K; Johnson L; Vozikis A; Patrinos GP
    Drug Metabol Drug Interact; 2011; 26(4):143-6. PubMed ID: 22017487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics in dermatology: tools for understanding gene-drug associations.
    Daneshjou R; Huddart R; Klein TE; Altman RB
    Semin Cutan Med Surg; 2019 Mar; 38(1):E19-E24. PubMed ID: 31051019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.